Morning Endurance Training and Adaptation in Mice

Exercise timing is increasingly recognized as a biological variable rather than a minor scheduling choice. In the reference study, Hesketh and colleagues tested whether the time at which endurance exercise is performed changes the subsequent training response in mice. Their work, Morning endurance training induces superior performance adaptations compared to afternoon training in mice, provides a longitudinal comparison of early- and late-active-phase training and places glycogen measurements alongside performance, body composition, and skeletal-muscle remodeling.

Study Background and Research Question

Endurance capacity varies across the day in both humans and rodents, with mice generally performing better later in their active period. Because mice are nocturnal, the study’s Zeitgeber-time design should not be read as a direct human morning-versus-afternoon comparison. ZT13 represents the early active phase shortly after the dark period begins, whereas ZT22 represents the late active phase. The authors use these time points to examine circadian exercise timing within the mouse activity cycle.

Previous work discussed by the authors linked daily performance differences partly to liver glycogen availability and showed that clock disruption can eliminate time-of-day differences in endurance. However, earlier training studies were short, including a two-week intervention. The central question was therefore whether a longer, six-week program performed at different circadian phases would produce different rates or magnitudes of adaptation. A related question was whether liver or skeletal-muscle glycogen, blood metabolites, mitochondrial markers, or contractile proteins could help explain any performance divergence.

Key Innovation from the Reference Study

The major innovation is the separation of acute time-of-day performance from chronic training adaptation. At baseline, mice evaluated in the late active phase had greater endurance capacity than mice evaluated in the early active phase. If the initial difference alone determined later outcomes, the late-active-phase group might have been expected to retain a clear advantage. Instead, the early-active-phase training group improved more rapidly and ultimately reached a similar performance level despite completing less absolute training work.

This design also improves interpretation of training dose. Running was prescribed at a percentage of each animal’s maximal capacity rather than as one identical absolute treadmill workload for all animals. That approach attempts to match relative exercise intensity while preserving the physiological distinction between training times. The result is not evidence that early-phase exercise is universally superior, but it is evidence that exercise timing can alter training efficiency under the experimental conditions used.

Methods and Experimental Design Insights

The study used female mice assigned to endurance training at either ZT13 or ZT22. Training was conducted on a treadmill five days per week for six weeks at 70% of each animal’s maximal capacity. Endurance performance was evaluated at baseline, week 3, and week 6. The investigators also assessed blood glucose and lactate, cage activity, body composition, liver and skeletal-muscle glycogen, and selected mitochondrial and contractile proteins. These parallel measurements allowed the authors to compare functional adaptation with metabolic and molecular phenotypes.

Protocol Parameters

• Animal model: Female mice were studied; the supplied study summary does not establish that the results apply across sex, strain, age, or disease state.
• Training times: Treadmill exercise was performed at ZT13 or ZT22, representing early- and late-active-phase training in nocturnal mice.
• Training dose: Exercise occurred five days per week for six weeks at 70% of each animal’s maximal capacity, as reported in the reference study.
• Performance testing: Endurance was assessed at baseline, week 3, and week 6 to capture both the trajectory and endpoint of adaptation.
• Metabolic endpoints: Blood glucose, lactate, body composition, and liver and skeletal-muscle glycogen were measured alongside activity and protein-level outcomes.
• Replication planning: Researchers extending this design should align tissue collection with training and testing time, record feeding conditions, and normalize glycogen measurements to tissue mass or protein using a prespecified procedure.

Core Findings and Why They Matter

Early-active-phase training accelerated improvement

The baseline performance difference favored ZT22-tested mice. After six weeks, however, ZT13-trained mice showed a 132% increase in endurance, compared with a 45% increase in the ZT22-trained group. By week 6, performance was improved in both groups but was no longer significantly different between them. The early-phase group therefore showed a larger rate of improvement and reached parity from a lower starting point, which supports the authors’ interpretation of enhanced training efficiency.

An important qualification is that the early-phase group completed lower absolute training volumes. Because exercise intensity was scaled to individual maximal capacity, the groups were not exposed to identical external workloads. The data consequently support a timing-dependent difference in adaptation under relative-intensity training, not a general conclusion that less work always produces more endurance.

Glycogen did not explain the final performance difference

Both training groups reduced fat mass by approximately 31–32% relative to their respective comparison condition, while lean mass, food intake, and muscle and liver glycogen content did not differ significantly between training times. These observations are important because glycogen is a plausible link between feeding rhythms, circadian regulation, and endurance exercise. In this six-week experiment, however, final tissue glycogen abundance was not aligned with the different rates of performance improvement.

The result should not be interpreted as proof that glycogen metabolism is irrelevant. A tissue glycogen measurement is a stored-pool measurement and may not capture glycogen turnover, depletion during the exercise bout, post-exercise resynthesis, or the timing of glycogen availability relative to testing. It does indicate that a simple endpoint comparison of total liver or muscle glycogen is insufficient to explain the superior adaptation observed in the ZT13 group.

Skeletal-muscle remodeling accompanied early-phase training

ZT13 training was associated with higher COXIV protein expression, greater citrate synthase activity, and changes in myosin heavy-chain isoform expression. These findings point toward remodeling of oxidative capacity and contractile phenotype. Notably, the study did not detect a difference in overall mitochondrial content. The distinction matters: increased oxidative enzyme activity or altered protein expression does not necessarily require a measurable expansion in mitochondrial abundance.

These molecular results are associative rather than mechanistic. They identify muscle adaptations that track with the stronger early-phase response, but they do not establish whether COXIV, citrate synthase, or myosin isoform changes cause the performance effect. They also leave open the possibility that neural, cardiovascular, substrate-utilization, or circadian-clock processes contribute to the outcome.

Comparison with Existing Internal Articles

The internal article Morning Training Improves Endurance Adaptation in Mice presents the same study as evidence that early-active-phase training produces faster and more efficient gains. Its emphasis is useful for a concise interpretation of the performance trajectory, whereas the reference paper provides the methodological context needed to understand why the result is not simply a consequence of greater workload.

A second related overview, Morning Endurance Training: Superior Adaptations in Mice, highlights circadian exercise design. Read alongside the primary paper, these summaries should be treated as contextual explanations rather than independent evidence. The strongest conclusions remain the reported differences in improvement rate, endpoint performance, glycogen content, and skeletal-muscle remodeling.

Limitations and Transferability

The most immediate limitation is species and time-base transferability. Mice are nocturnal, so ZT13 and ZT22 do not map directly onto human morning and afternoon exercise. Human chronotype, sleep timing, meals, habitual activity, and environmental light exposure could all modify the response. The use of female mice is valuable but also means that the findings should not automatically be generalized to male animals or to people with different hormonal or metabolic states.

The intervention lasted six weeks, which is longer than the short training periods criticized in the introduction but still limited for a chronic adaptation study. The final similarity in performance also means that the paper demonstrates a faster trajectory rather than a permanently higher endpoint. In addition, training at 70% of individual maximal capacity creates a relative-intensity comparison; other results might emerge from matched absolute speed, matched distance, high-intensity intervals, or voluntary exercise.

Glycogen interpretation has analytical limitations as well. The reported absence of a final difference in liver or muscle glycogen does not resolve when samples were most informative relative to feeding, exercise, and recovery. Measurements of glycogen concentration also require careful extraction, hydrolysis, normalization, and control of matrix interference. Finally, changes in COXIV, citrate synthase activity, and myosin heavy-chain expression are useful phenotype markers, but the study does not by itself identify the upstream circadian mechanism or prove causality.

Why this cross-domain matters, maturity, and limitations

Connecting circadian exercise physiology with biochemical glycogen measurement is useful because the paper treats glycogen as an explanatory metabolic endpoint, not merely as a descriptive variable. A reliable glycogen quantification assay can help test whether different collection times, exercise challenges, or recovery intervals reveal changes that are missed by a single endpoint measurement. This bridge is mature enough to support experimental planning, but it does not convert the present mouse findings into a validated human protocol.

For follow-up studies, a glycogen hydrolysis assay based on enzymatic conversion to glucose can be paired with matched liver and muscle extracts. A glucose oxidation colorimetric assay may then provide a practical readout, provided investigators verify linearity, recovery, dilution effects, tissue normalization, and interference from reducing substances. These analytical steps complement the reference study; they do not show that glycogen caused the observed training adaptation.

Research Support Resources

For researchers extending this model, APExBIO’s Glycogen Colorimetric Assay Kit II (SKU K2144) can support glycogen measurement in biological samples through enzymatic hydrolysis followed by glucose oxidation and colorimetric detection. The product information reports absorbance at 450 nm, sensitivity down to 4 µg/mL, and compatibility considerations for samples containing reducing substances. It may fit a high-throughput glycogen assay workflow, but researchers should validate extraction, standard curves, recovery, normalization, and matrix effects for their tissue model. The stated biochemical assay kit storage condition is −20°C.